biotech

Growing pains

SINGAPORE (Sept 2): From this month, tech firms in Singapore can look forward to an expansion of their ranks, as a government scheme to facilitate global hiring takes effect. The Tech @ SG scheme, launched at end-July and scheduled to start in the coming months, is aimed at helping companies find talent in deep tech sectors, including medtech, cleantech, fintech, agritech and biotech.

The deep tech void

Singapore’s high-tech ambitions are not quite matched by the depth of its local talent pool. While attracting employees from abroad, the city state must also build up its domestic workforce if it sees tech as its future.

Categories: 

Clearbridge Health rides on China's biotech boom for cancer diagnostic spinoff

SINGAPORE (Aug 31): Investors and foreign biotech veterans are making their way to China as the government aims to build a healthcare empire.

Jeremy Yee, former CEO of Cordlife Group and now running his second healthcare company Clearbridge Health, hopes to tap into that optimism. He plans to spin off a cancer diagnostics associate company that is aiming to expand into China, and buy more testing laboratories in the region. Yee hopes these moves will help revive investor interest in Clearbridge.

This undervalued chemical player is a proxy to global economic growth, says SAC Advisors

SINGAPORE (June 26): SAC Advisors is starting coverage on Megachem at “buy” with a target price of 50 cents, which translates into 14.9 times FY19P/E to imply a 26% discount to the sector average.

In an initiation report on Tuesday, analyst Eing Kar Mei highlights the speciality chemicals provider as a proxy to the stronger global economy with an attractive dividend yield of 4.8-5.7%.

Singapore’s tech & business services companies see highest levels of M&A activity

SINGAPORE (June 2): Singapore’s merger and acquisition (M&A) landscape saw a total of 56 deals worth US$13.8 billion ($19.1 billion) from Jan 2014 to April 2017, based on data compiled by Mergermarket Group, the media company specialising in corporate financial news and analysis.  

This represents a market share of 4.1% by deal count in the Asia Pacific region, which posted a total of 125 deals worth US$35.6 billion over the first quarter of 2017 alone – up 19.6% compared to the same period a year ago when 21 fewer deals were recorded.

Be informed of the stories that matter